The use of extracorporeal photopheresis in solid organ transplantation—current status and future directions [PDF]
\ua9 2024 The AuthorsPrevention and management of allograft rejection urgently require more effective therapeutic solutions. Current immunosuppressive therapies used in solid organ transplantation, while effective in reducing the risk of acute rejection,
Barten MJ, Fisher AJ, Hertig A
core
Ruxolitinib Plus Extracorporeal Photopheresis for Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease. [PDF]
Halahleh K +8 more
europepmc +1 more source
Extracorporeal photopheresis for pembrolizumab-induced dermatitis: a case report. [PDF]
Zenderowski V +4 more
europepmc +1 more source
Extracorporeal photopheresis for refractory BK virus-associated nephropathy in kidney transplantation. [PDF]
Escudero-Saiz VJ +15 more
europepmc +1 more source
Extracorporeal photopheresis and liver transplantation: Our experience and preliminary data [PDF]
Bianco, I. +12 more
core +1 more source
Extracorporeal Photopheresis: Does It Have a Potential Place Among Cell-based Therapies? [PDF]
Parsonidis P, Wekerle T.
europepmc +1 more source
Use of Extracorporeal Photopheresis Treatment Over Time (2001-2023) in Alberta, Canada: A Retrospective Cohort Study. [PDF]
Girard L +7 more
europepmc +1 more source
Current Usage of Extracorporeal Photopheresis in Solid Organ Transplantations in Europe: A Narrative Review. [PDF]
Cashmore SJ +13 more
europepmc +1 more source
Potential Impact of Extracorporeal Photopheresis on Trained Immunity and Organ Transplant Acceptance. [PDF]
Tocco C, Ochando J.
europepmc +1 more source
Evaluation of the Cellular Resistance Process in Treated Cells Via Extracorporeal Photopheresis. [PDF]
Arjmand B +5 more
europepmc +1 more source

